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Validity of single item responses to short
message service texts to monitor
depression: an mHealth sub-study of the
UK ACUDep trial
Ada Keding1*, Jan R. Böhnke1,2, Tim J. Croudace3, Stewart J. Richmond4 and Hugh MacPherson1
Abstract
Background: An increasing number of research designs are using text messaging (SMS) as a means of self-reported
symptom and outcome monitoring in a variety of long-term health conditions, including severity ratings of depressed
mood. The validity of such a single item SMS score to measure latent depression is not currently known and is
vital if SMS data are to inform clinical evaluation in the future.
Methods: A sub-set of depressed participants in the UK ACUDep trial submitted a single SMS text score (R-SMS-DS)
between 1 and 9 on how depressed they felt around the same time as completing the PHQ-9 depression questionnaire
on paper at 3 months follow-up of the trial. Exploratory categorical data factor analysis (EFA) was used to ascertain the
alignment of R-SMS-DS scores with the factor structure of the PHQ-9. Any response bias with regard to age or gender
was assessed by differential item functioning (DIF) analysis.
Results: Depression scores based on the PHQ-9 and R-SMS-DS at 3 months were available for 337 participants
(74 % female; mean age: 42 years, SD = 11.1), 213 of which completed the two outcomes within 6 days of each
other. R-SMS-DS scores aligned with the underlying latent depression of the PHQ-9 (factor loading of 0.656) and in
particular its affective rather than somatic dimension. The R-SMS-DS score was most strongly correlated with depressed
mood (r = 0.607), feeling bad about oneself (r = 0.588) and anhedonia (r = 0.573). R-SMS-DS responses were invariant
with respect to gender (p = 0.302). However, there was some evidence for age related response bias (p = 0.031), with
older participants being more likely to endorse lower R-SMS-DS scores than younger ones.
Conclusions: The R-SMS-DS used in the ACUDep trial was found to be a valid measure of latent affective depression
with no gender related response bias. This text message item may therefore represent a useful assessment and
monitoring tool meriting evaluation in further research. For future study designs we recommend the collection of
outcome data by new health technologies in combination with gold standard instruments to ensure concurrent validity.
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Background
Depression is a debilitating long-term health condition
that is one of the leading causes of global disease burden
[1, 2], and its management presents a major challenge to
health care providers worldwide. As part of an emerging
trend to utilise mobile devices in health care (mHealth)
[3], ubiquitous mobile technologies such as short mes-
sage service (SMS or text messaging) may offer a cheap
and straightforward support tool to monitor outcomes
in clinical care and self-management of depression and
other chronic health conditions [4]. Text messaging has
already been studied in the management of diabetes [5–7],
asthma [8–10], lower back pain [11–13] and irritable
bowel syndrome [14] for example, as well as in the sup-
port of long-term health behaviour change interventions
such as weight loss [15, 16] and smoking cessation [17].
While the importance of validating health outcomes
collected by text messaging has been recognised, few of
the studies using SMS technology have implemented
this [18, 19].
Within mental health, research has primarily focussed
on utilising text messaging for the management of bi-
polar disorder and schizophrenia. Feasible symptom
monitoring was demonstrated when gathering weekly
responses of validated questionnaires for depression
and mania from bipolar patients [20] and when collect-
ing daily outcomes on several symptom dimensions
from patients suffering from schizophrenia [21]. Fur-
thermore, when employed as a low level intervention in
schizophrenia, customised daily text prompts for differ-
ent illness aspects improved outcomes in those areas
[22], and weekly monitoring of early warning signs by
patients and relatives improved rates of relapse and
hospital readmission [23].
Until recently, only a small number of studies with few
participants had looked specifically at the possibility of
collecting depression outcomes by text message. A single
item SMS subjective distress rating (scale 0 to 10) was
used for daily mood monitoring in patients with anxiety
or depression in a remote Australian community during
and after treatment [24], and a daily SMS mood score
(scale 1 to 9) was collected as an adjunct to cognitive be-
havioural therapy (CBT) for outpatients from different
ethnic groups in the United States [25–27]. These stud-
ies found mood data collection by SMS feasible, accept-
able, and predictive of PHQ-9 [28] depression scores.
This has been further confirmed in a sub-study of the
UK ACUDep trial [29], which collected weekly depres-
sion scores (scale 1 to 9) by text message from over 500
depressed adult participants during the first 3 months of
trial follow-up [30]. The study demonstrated good re-
sponse rates (94 % of patients responded to at least one
text prompt, and patients replied to an average of 12.5
(SD = 3.45) of 15 texts), the depression rating correlated
well with the PHQ-9 measure of depression (Kendall’s
tau-b = 0.570), and SMS depression scores were sensitive
to change in response to the trial treatments.
Monitoring patient depression with such a simple,
single SMS text score instead of the administration of
lengthy questionnaires represents an attractive mode of
data collection in view of compliance rates and patient
burden. This is in line with other efforts to condense
the measurement of depression into one or two items
for the purpose of efficient patient screening and moni-
toring [31–34]. The choice between long and short
form assessment tools will depend on the context and
purpose of the evaluation, balancing ease of data collec-
tion with the need for robust clinical diagnoses [35]. It
remains unknown whether a single SMS depression score,
as used in the ACUDep trial, can be considered a valid
measure of depression and could consequently be recom-
mended for use in research and evaluation in clinical
practice.
The present study therefore aimed to establish the val-
idity of the ACUDep SMS depression score (termed R-
SMS-DS [30]), by employing item response theory meth-
odologies. If scores obtained for the R-SMS-DS and the
PHQ-9 both measure the same latent depression vari-
able, then this could be confirmed by including all indi-
vidual items in a factor analysis. The PHQ-9 has
variously been shown to be either uni-dimensional in
primary care patients [36–39], or to divide into an
affective and somatic dimension in certain patient popu-
lations [40–43]. It was of interest whether R-SMS-DS
scores would align with either one of these dimensions if
present in the ACUDep patient sample.
Depression prevalence, symptomatology and trajec-
tories are known to differ between men and women
[44–46] as well as over the course of life [45, 47]. Al-
though the reasons for these disparities remain debated,
they may be connected to differential use of health care
systems [48] and important aspects of depression treat-
ment [49]. It is therefore important that these demo-
graphic groups do not differ in the way they use the R-
SMS-DS, and score differences between individuals
only reflect variations in their respective levels of de-
pression [50]. Therefore the present study also aimed
to assess any response bias for the R-SMS-DS with re-
spect to age and gender. The absence or presence of
such biases will provide evidence for the relative impact
of these factors on the measurement of depression with
the R-SMS-DS, before it can be considered to inform valid
treatment decisions in clinical practice.
Results of this study were anticipated to inform rec-
ommendations for whether and how the increasing
number of research studies using mHealth technologies
for patient monitoring should incorporate these tools
and their validation into their study designs.
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Methods
Participants
Participants included in this study took part in the
ACUDep trial [29], a three arm randomised controlled
trial that evaluated the effectiveness of acupuncture or
counselling compared to standard care in a population of
depressed adults in the North of England. Participants
were 18 years of age or older, had consulted for depression
within the previous five years and had ongoing depression
with a score of 20 or above on the Beck Depression Inven-
tory (BDI-II) [51]. Those recruited into the trial were in-
vited to take part in an optional sub-study involving the
use of weekly SMS text messages to monitor their depres-
sion. 755 patients were recruited into the ACUDep trial
between 2009 and 2011, and 527 of these consented to the
SMS sub-study.
Design
In order to investigate the validity of the R-SMS-DS [30]
as a measure of depression, this study exploited the
collection of the last of 15 weekly SMS text scores and
PHQ-9 depression by questionnaire around the same
time at 3 months follow-up of the trial. Participants were
considered as a single patient group for this purpose, ir-
respective of their allocated trial arm. The differences in
R-SMS-DS scores between treatment groups in patients’
depression trajectories are reported elsewhere [30]. We
used categorical data factor analysis [52] to ascertain the
factor structure of the PHQ-9 in the present patient
sample and the alignment of the R-SMS-DS with that
structure. Following these exploratory analyses we used
differential item functioning (DIF) analysis to investigate
potential response bias with respect to age or gender.
Outcome measures
The PHQ-9 [28] is a nine-item depression scale based
on the DSM-IV symptom criteria for major depressive
disorder [53]. It is used routinely as a screening tool in
clinical practice and as a standard depression severity
outcome in research. Each item is scored between 0 and
Fig. 1 PHQ-9 Questionnaire Wording (Source: Kroenke et al. 2001)
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3, thus PHQ-9 total scores range from 0 to 27 with
higher scores indicating greater depression (see Fig. 1
for complete wording of the PHQ-9). The instrument
was completed by patients at baseline and follow-up on
paper questionnaires, and the total score at 3 months
served as the ACUDep primary endpoint.
The weekly R-SMS-DS text message sent to patients
who consented to the sub-study contained the text:
‘ACUDep Trial: Over the last week how depressed have
you felt on average? Please reply with a score between 1
and 9; where 1 is “not at all” and 9 is “extremely”’. Up to
15 weekly text messages were sent to participants fol-
lowing randomisation, the final text approximately coin-
ciding with 3 months follow-up. Received participant
texts were matched to the text they were responding to,
and text content was validated to arrive at a single score
for each responding patient between 1 and 9, allowing half
scores if patients submitted these or two adjacent scores.
Statistical analysis
Exploratory Factor Analyses (EFAs) were conducted for
three groupings of ACUDep participants at 3 months
follow-up: Group 1 comprised patients with complete
PHQ-9 items; Group 2 were patients with complete PHQ-9
items and a valid R-SMS-DS score; and Group 3 were pa-
tients with complete PHQ-9 items and a valid R-SMS-DS
score completed within 6 days of each other. Previous re-
search suggests that PHQ-9 scores are associated with aver-
age texted mood ratings over 1 week, but not 2 weeks [27].
Group 1 was used to inform the factor structure of the
PHQ-9, whereas the alignment of R-SMS-DS scores with
PHQ-9 depression was explored in Groups 2 and 3, with
greater agreement expected in the temporally closer assess-
ments in Group 3.
All EFAs were computed using FACTOR 9.2 [54], using
polychoric correlations in a parallel, minimum rank factor
analysis with oblique (promin) rotation. One- and two-
factor solutions were implemented as suggested by previous
structural analyses of the PHQ-9 [36–43]. Optimal dimen-
sionality of the item set was established, for which parallel
analysis has been shown to be highly efficient [55–57]. It
determines eigenvalues for random data matrices and es-
tablishes a cut-off (above 95 % based on random data) to
retain relevant factors only, i.e. those that capture more
common variance between the items than expected purely
by chance. Item correlations between all item pairs were
extracted from the analyses as well as factor loadings for
the one- and two-factor models, suppressing any loadings
less than 0.400. Emphasis of these analyses was on the fit
of the R-SMS-DS score with the PHQ-9 factor structure.
Differential Item Functioning (DIF) with respect to age
and gender was investigated by ordinal logistic regression
[58, 59] in Stata version 12 [60]. The analyses included all
patients with complete PHQ-9 and R-SMS-DS data at 3
months (Group 2), predicting R-SMS-DS score (values 1 to
9) from age or gender (uniform DIF) and their interaction
with the PHQ-9 (non-uniform DIF, i.e. any bias that was
dependent on the level of latent depression). The regression
models controlled for latent depression as measured by the
total PHQ-9 score at 3 months follow-up, which was ex-
pected to be highly correlated with the R-SMS-DS score,
reflecting that both assess the same underlying depression
construct. Evidence for response bias would be found if
age, gender or their interactions with the PHQ-9 signifi-
cantly (p < 0.05) predicted the R-SMS-DS over and above
the PHQ-9 total score, potentially rendering comparisons
between them unfair [50]. The direction of any identified
DIF was explored, and the DIF effect size determined by
comparison of pseudo R2 values between the analysis
models and a base model including PHQ-9 total score as
the only predictor. Continuous variables (age and PHQ-9)
were centred for all analyses.
Ethical approval and consent
Full ethical approval for the trial was granted by York
NHS Research Ethics Committee on 21st September
2009 (ref: 09/H1311/75), together with research govern-
ance approval shortly thereafter from North Yorkshire &
York Primary Care Trust. All participants provided in-
formed written consent.
Results
Data availability and baseline characteristics
Of 755 randomised ACUDep trial participants, 602
patients had complete PHQ-9 data for all items at 3
months follow-up (Group 1). Of the 527 ACUDep partici-
pants who additionally consented to take part in the SMS
sub-study, 373 patients responded with a valid text mes-
sage to their last follow-up SMS, which broadly coincided
with the 3-month PHQ-9 follow-up time point. Of these,
337 had complete PHQ-9 data (Group 2). PHQ-9 ques-
tionnaires were completed on average 8 days from
responding to the R-SMS-DS (range −8 to 75 days, com-
pletion date missing for 11 patients), and 213 patients
(63 %) completed these outcomes within 6 days (Group
3). Baseline characteristics for all randomised ACUDep
patients and the different patient groups included in the
factor analyses are given in Table 1. Apart from fewer re-
tired patients in Group 3, the demographic profile did not
substantially differ between groups.
Factor analyses
Results of all factor analyses are presented in Table 2.
The initial EFA of the PHQ-9 using all available data
(Group 1, n = 602) confirmed the uni-dimensional struc-
ture of the scale, with the first identified factor explain-
ing 64 % of the variance and being the only one that
captured more common variance than expected by
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Table 1 Baseline characteristics of different analysis populations
Characteristic Total patients in
ACUDep trial
n = 755
Group 1 Patients with
PHQ-9 score at 3 months
n = 602
Group 2 Patients with PHQ-9 score at
3 months & R-SMS-DS at 3 months
(any time) n = 337
Group 3 Patients with PHQ-9 score at
3 months & R-SMS-DS at 3 months
(±6 days) n = 213
Age
Mean (SD) 43.5 (13.37) 44.7 (13.14) 42.2 (11.13) 42.5 (11.18)
Median (min, max) 43 (18, 93) 43.5 (18, 89) 42 (18, 75) 42 (18, 75)
Gender, n (%)
Male 201 (26.6) 159 (26.4) 86 (25.5) 50 (23.5)
Female 554 (73.4) 443 (73.6) 251 (74.5) 163 (76.5)
Employment, n (%)
Working full-time 281 (37.2) 223 (37.0) 140 (41.5) 80 (37.6)
Working part-time 144 (19.1) 116 (19.3) 63 (18.7) 47 (22.1)
Unable to work 95 (12.6) 69 (11.5) 36 (10.7) 20 (9.4)
Looking after home 83 (11.0) 62 (10.3) 37 (11.0) 25 (11.7)
Retired 65 (8.6) 61 (10.1) 15 (4.5) 10 (4.7)
Full-time education 23 (3.0) 17 (2.8) 13 (3.9) 8 (3.8)
Other 48 (6.4) 40 (6.6) 23 (6.8) 18 (8.5)
Missing 16 (2.1) 14 (2.3) 10 (3.0) 5 (2.3)
Depression, mean (SD)
Age at 1st major
episode
25.2 (12.28) 25.6 (12.51) 23.8 (11.03) 24.9 (11.66)
Baseline BDI-II 32.5 (8.72) 32.1 (8.62) 31.8 (8.54) 31.5 (8.27)
Baseline PHQ-9 16.0 (5.29) 15.7 (5.32) 15.6 (5.48) 15.4 (5.29)
Table 2 Summary of exploratory factor analysis item factor loadingsa of PHQ-9 and R-SMS-DS scores at 3 months follow-up
Group 1 Group 2 Group 3
N = 602 patients with PHQ-9 N = 337 patients with PHQ-9 &
R-SMS-DS (any time)
N = 213 patients with PHQ-9 &
R-SMS-DS (within 6 days)
Loadings Loadings Loadings
One-Factor Affective Somatic One-Factor Affective Somatic One-Factor Affective Somatic
PHQ-9 Item Descriptive/Variance explained 64 % — 73 % — 61 % — 69 % — 61 % — 70 % —
1. Loss of interest (anhedonia) .852 .632 - .855 .540 - .854 .448 .453
2. Depressed mood .856 .875 - .876 .768 - .882 .683 -
3. Sleep disturbance .778 - .942 .761 - .973 .740 - .994
4. Fatigue .794 - 1.078 .794 - 1.041 .779 - .831
5. Appetite changes .718 - .640 .700 - .617 .719 - .573
6. Feeling bad about oneself .816 .972 - .840 1.244 - .846 1.169 -
7. Concentration difficulties .791 .554 - .738 .411 - .746 - .634
8. Psychomotor disturbance .735 .507 - .690 .405 - .700 - .714
9. Thoughts of death or self-harm .704 .894 - .724 .860 - .719 .826 -
R-SMS-DS: ‘How depressed have you felt?’ n/ab n/ab n/ab .656 .501 - .692 .616 -
Correlation between factors — .834 — — .820 — —.793 —
aLoadings < 0.400 suppressed
bGroup 1 analyses excluded the SMS score, as this was not available for all patients
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chance (parallel analysis). Individual item loadings were
high and ranged between 0.704 and 0.856. When forced
into a two-factor solution, the PHQ-9 items divided into
two highly correlated (0.834) dimensions consistent with
previous findings: a factor of somatic symptoms (sleep,
fatigue, appetite) and a factor of affective symptoms rep-
resented by the remaining six depression items.
When including the R-SMS-DS score in the analyses
(Table 3), the PHQ-9 items that correlated most strongly
for any patients with both outcomes (Group 2) were de-
pressed mood (0.607), feeling bad about oneself (0.588)
and anhedonia (0.573). Correlations for the sub-set of
patients whose R-SMS-DS and PHQ-9 responses were
given within 6 days (Group 3) exhibited a similar pattern
and were generally higher, with the exception of sleep
and psychomotor disturbance. These mainly somatic
depression symptoms correlated more strongly with the
R-SMS-DS score when assessments were more widely
spaced in time (see Table 3).
When R-SMS-DS scores were included in the factor
analyses (Table 2), the one-factor structure remained the
optimal description of the data (parallel analysis; 61 %
explained variance). The R-SMS-DS text score loaded
moderately highly onto the underlying depression factor:
0.656 in the overall model (Group 2) and 0.692 for texts
within 6 days of PHQ-9 completion (Group 3). When
analysed as a two-factor solution, the R-SMS-DS score
aligned with the six items of the PHQ-9 affective dimen-
sion (0.501 for Group 2 patients). The two-factor struc-
ture altered slightly when using the sample of patients
who responded within 6 days (Group 3): PHQ-9 items
for concentration difficulties and psychomotor disturb-
ance now loaded predominantly onto the somatic dimen-
sion, and anhedonia loaded equally onto the affective and
somatic dimension. The R-SMS-DS score still aligned with
the dimension made up of the remaining core affective
items (0.616), comprising depressed mood, feeling bad
about oneself and having thoughts of dying or self-harm.
The two dimensions remained highly correlated however
(0.793), and the parallel analysis identified a one-factor so-
lution as optimal in this sample too, explaining 61 % of
the variance.
In summary, the R-SMS-DS was shown to pick up on
the same underlying depression as the PHQ-9, in par-
ticular the affective dimension of depression.
Response bias
Following results of the EFAs, the specified PHQ-9 total
score in the logistic DIF regressions was replaced with
the affective sub-score PHQ-9A, calculated as the sum of
the PHQ-9 affective items (Items 1,2,6,7,8,9). Although
according to the results of the parallel analysis a one factor
solution described the responses to all items, we used the
PHQ-9A as a measure with maximum uni-dimensionality,
thereby providing a more concise estimate of the charac-
teristic being measured by the R-SMS-DS than the total
score. The resulting regression coefficients were expressed
as odds ratios and are presented in Table 4.
The DIF analysis for age revealed no evidence for non-
uniform DIF (p = 0.271) but some evidence for uniform
age related DIF (p = 0.031), change in pseudo R2 = 0.004.
Using predicted endorsements of each R-SMS-DS value
based on the regression model, we found older
Table 3 Polychoric correlations between R-SMS-DS score and PHQ-9 items
PHQ-9 items Group 2 Group 3 Grp 2 - Grp 3
Patients with PHQ-9 & R-SMS-DS
(any time) N = 337
Patients with PHQ-9 & R-SMS-DS
(within 6 days) N = 213
Patients with PHQ-9 & R-SMS-DS
(outside 6 days) N = 113
1. Loss of interest (anhedonia) .573 .593 .545
2. Depressed mood .607 .619 .561
3. Sleep disturbance .474 .458 .517
4. Fatigue .479 .487 .481
5. Appetite changes .472 .513 .425
6. Feeling bad about oneself .588 .665 .454
7. Concentration difficulties .450 .485 .414
8. Psychomotor disturbance .421 .404 .473
9. Thoughts of death/self-harm .436 .472 .381
Table 4 DIF ordinal logistic regression results (Group 2, n = 337)
Predictor Odds ratio SE 95 % CI p
Age DIF analysis
Age 0.98 0.009 0.96, 1.00 .031
Age x PHQ-9A 1.00 0.002 1.00, 1.01 .271
PHQ-9A 1.46 0.044 1.38, 1.55 <.001
Gender DIF analysis
Gender (being female) 1.26 0.280 0.81, 1.95 .302
Gender x PHQ-9A 1.07 0.061 0.95, 1.19 .250
PHQ-9A 1.39 0.073 1.25, 1.54 <.001
PHQ-9A = Sum of affective PHQ-9 items (Items 1,2,6,7,8,9)
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participants being more likely to use lower scores in
their text responses (R-SMS-DS scores of 1 to 3) and
less likely to use higher scores (R-SMS-DS scores of 5 to
9) compared to younger participants with the same level
of affective depression (PHQ-9A). The DIF analysis for
gender revealed no evidence for uniform DIF (p = 0.302)
nor non-uniform DIF (p = 0.250), change in pseudo R2 =
0.002. Thus results of the DIF analyses suggest some evi-
dence of age related response bias but not gender bias
for the R-SMS-DS.
Discussion
The present study set out to validate a single depression
rating item submitted by SMS text message (R-SMS-DS)
against data of the widely validated PHQ-9 concurrently
collected by post, which were available for a depressed
adult sub-population of the UK ACUDep trial. R-SMS-DS
scores were found to correlate well with latent depression
when included in a combined single-factor solution ex-
planatory factor analysis with the individual PHQ-9 items.
The most closely associated PHQ-9 items were the two
core DSM-IV criteria of depressed mood and anhedonia
as well as feeling bad about oneself. The correlations
closely mirrored those observed for a single-item paper
based depression severity rating when correlated with
DSM-IV criteria in a population of psychiatric outpa-
tients undergoing treatment for major depression [32].
With the exception of sleep and psychomotor disturbances,
item correlations were larger when patients completed
the two assessments closer in time, therefore results
suggest that the R-SMS-DS score did indeed measure
depression as desired.
While the optimal one-factor model in this study lent
further support to the uni-dimensionality of the PHQ-9,
it was unsurprising to find that R-SMS-DS ratings aligned
with the affective rather than somatic dimension of de-
pression in the pre-specified two-factor analyses. This
raises the possibility of complementing the R-SMS-DS
with one or more physical symptom questions if monitor-
ing of the somatic depression dimension is additionally de-
sired. Sleep, fatigue and appetite were picked up as core
somatic symptoms in line with all previous studies of a
two-dimensional PHQ-9 structure. Interestingly, a model
with these three symptoms alone forming the somatic di-
mension (found in selected previous research [40, 42, 61])
was supported in patients who had both valid PHQ-9 data
and patients with valid PHQ-9 and any R-SMS-DS data;
whereas the most commonly observed two-factor struc-
ture [40, 41, 43, 62] with the additional two somatic items
of concentration difficulties and psychomotor disturbance
was only observed in the sub-set of patients whose PHQ-9
and R-SMS-DS responses were closer in time (within 6
days). The possible loading of anhedonia on the somatic
dimension for these patients had previously only been
recorded in one study of spinal cord injury patients at a
single long-term follow-up point [40]. Patient characteris-
tics in terms of demographics and baseline depression did
not appear to differ for patients in this group, so it may be
the result of differences in other patient characteristics,
such as present comorbidities affecting the rating of som-
atic symptoms. Alternatively the model factors may be less
stable in this group as the smallest analysed sub-sample.
Consistent use of the R-SMS-DS was demonstrated
across men and women. However, older patients were
found to be less likely to endorse higher scores even
when their degree of latent depression (as defined by
the PHQ-9) was indicative of such an elevated level.
This could be a result of a different understanding of the
‘feeling depressed’ terminology used in the text message,
which has been discussed in the epidemiological literature
of depression both as a shift towards a more somatically
driven concept or as confounding with other somatic mor-
bidities [63, 64]. Further reasons could be different attitudes
towards communicating mental wellbeing by mobile tech-
nologies or a greater reluctance to potentially arouse cause
for concern. Such age bias could affect the sensitivity of the
R-SMS-DS score if used for depression screening, however
it is unlikely for that to be its primary use. We envisage the
R-SMS-DS as a monitoring tool for patients who have
already undergone formal depression assessment. The dir-
ection of the age bias was opposite to that identified in a
sample of UK primary care patients for the PHQ-9 items of
low mood and anhedonia for patients aged 55 and over
[65]. It remains possible that the observed bias in this study
is a consequence of the relatively small total sample size or
the small number of older patients in the sample. While we
used age as a continuous predictor, the number of patients
for whom the effect was identified based on marginal effect
plots was rather low (n = 8 participants ≥ 65 years, 2.4 %).
Moreover, the magnitude of the association between age
and R-SMS-DS score (OR = 0.98) was only weak [66], and
the effect size in terms of pseudo R2 [67] was negligible.
The stability of this bias remains to be confirmed in a larger
patient sample including a qualitative assessment of
possible reasons.
Overall, results of this study add further support to the
validity of collecting depression severity outcomes by
SMS, which had already been shown to be feasible and
acceptable in adults with ongoing depression in primary
care in the ACUDep trial [30]. To our knowledge, this is
the first study aiming to validate an SMS self-report tool
for depression using item-response theory methodologies,
and results are strengthened by the use of a gold standard
validated patient self-report depression instrument (PHQ-
9) based on DSM-IV criteria for comparison. Despite the
relatively small sample size of this study, patients agreeing
to submit weekly text messages and who were included
in the present analyses were representative of those taking
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part in the ACUDep trial (Table 1), who in turn were
typical of adults in the UK with ongoing depression in
primary care.
However, findings cannot be extrapolated to patients
who are presenting with depression for the first time or
who do not consult in primary care at all. A further limi-
tation includes the temporal difference between PHQ-9
and R-SMS-DS data completion, which had not been
designed to be collected concurrently, resulting in consider-
able between-patient variability in the time between com-
pleting the assessments. In addition, the reference time
frame differed for the two measures (PHQ-9: over the
last two weeks; R-SMS-DS: average over the last week),
therefore it is not certain whether patients were in the
same mental state when reporting those outcomes. In-
deed the positive findings of this study may only repre-
sent a conservative estimate of the level of association.
However, the depression outcomes linked with one an-
other in this study were patient reported only, and no
independent assessment was carried out in order to
confirm clinical validity. Moreover, only the association
between R-SMS-DS and a single screening tool (PHQ-9)
has been demonstrated so far, and further convergent val-
idity needs be shown in order to establish the R-SMS-DS
as a valid estimate of latent depression. Capturing the full
multi-faceted nature of depression will never be possible
by a single item, and this is not the aim of the R-SMS-DS
monitoring tool.
For future studies we suggest to include at least one
assessment that allows researchers to test the concurrent
validity of their novel electronic or mHealth tools with a
gold standard instrument collected at the same time, an
approach that has not yet been widely adopted. The
shortcomings of this study could be addressed by a more
controlled, dedicated design, either as standalone work
or embedded in larger investigations, with particular at-
tention to the magnitude and context of any response
bias. The successful use of tools from the framework of
item response theory for the validation of SMS scores at
a single time point might also be extended to investigate
the longitudinal validity of the R-SMS-DS scores, which
had been collected weekly over 3 months. Notwithstand-
ing such further methodological work, we believe that
findings from the present and a previous study [30] have
provided sufficient evidence for the feasibility, accept-
ability and validity of the R-SMS-DS for monitoring de-
pression in the ACUDep study population. Given these
findings, we encourage investigators and clinicians to in-
corporate the R-SMS-DS as a free to use outcome meas-
ure in the study of depression management in different
clinical populations. If verified against other validated
depression measures and found acceptable in different
clinical contexts, the R-SMS-DS could be considered for
use in routine clinical practice.
Conclusions
This study has demonstrated that the self-report R-SMS-
DS depression item used in the ACUDep trial was a
valid measure of the affective dimension of depression in
this study population. In agreement with previous find-
ings, the R-SMS-DS may therefore represent a useful as-
sessment and monitoring tool meriting evaluation in
further research.
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